Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: A case report
β Scribed by Alex Costea; Geetha Bhat
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 55 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Homocysteine has been recognized as a risk factor for atherosclerosis and arterial and venous thrombosis. Heart transplant patients have an increased prevalence of hyperhomocysteinemia. High homocysteine levels in transplant patients may promote development of cardiac allograft vasculopathy, but there is minimal information regarding the risk of venous thrombosis. The current case report illustrates the association of increased levels of homocysteine and hypercoagulable syndrome in a 36βyearβold heart transplant patient with no previous history of clotting disorder. Both elevated homocysteine levels and extensive venous thrombosis responded promptly to treatment with a folate/B~12~/B~6~ vitamin combination and enoxaparin. Am. J. Hematol. 77:161β163, 2004. Β© 2004 WileyβLiss, Inc.
π SIMILAR VOLUMES
Congenital absence of portal vein and extrahepatic portocaval shunt, also referred to as an Abernethy type 1, is a rare malformation of the mesenteric vasculature. A 9-year-old girl presented with dyspnea on exertion and orthodeoxia. A diagnosis of an Abernethy malformation type 1b and hepatopulmona